# Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer

> **NCT00003450** · PHASE1 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Ovarian Cancer
- Peritoneal Cavity Cancer

## Interventions

- **BIOLOGICAL:** Ad5CMV-p53 gene

## Key facts

- **NCT ID:** NCT00003450
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** 1999-01
- **Final completion:** 1999-01
- **Target enrollment:** — (—)
- **Last updated:** 2021-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003450, "Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*